![](https://endpts.com/wp-content/uploads/2022/07/Yusuf-Erkul-Burak-Yilmaz-Kernal-Biologics-tile.jpg)
Kernal Biologics co-founders Yusuf Erkul (L) and Burak Yilmaz
Pushing mRNA therapeutics for cancer, Cambridge startup nabs Series A to explore next-gen approach
With increased interest in mRNA therapeutics thanks to Pfizer and Moderna’s megablockbuster Covid-19 vaccines, a new startup located next to MIT is getting infused with …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.